| Literature DB >> 32055686 |
Bikash Bikram Thapa1, Vikram Niranjan2.
Abstract
The incidence of small- and medium-size renal stones is rising. Stone clearance, bleeding, urine leak, and infectious complications are major concerns for urologists. They can choose the best technique from a list of armamentarium available. Minimally invasive approach like percutaneous nephrolithotomy (PCNL) has significantly influenced renal stone management since 1976. Miniaturization of the instruments innovate more effective and safer alternatives for urolithasis management. The outcome of mini-PCNL is explored and compared with standard PCNL in this review. Original research articles were reviewed using a systematic approach (keyword electronic database search). Duplicates were excluded in each step and 19 original articles out of 156 hits were analyzed. Mini-PCNL has significantly less bleeding complications and hospital stay. There were no significant difference in stone free rate between mini-PCNL and standard PCNL. The stone-free rate and complications rates were less dependent on the technique of puncture, tract dilatation, and energy used to fragment stones. The total operative time became slightly longer in mini-PCNL attributed to the sheath size and stone fragments retrieval. We found that mini-PCNL is as effective as standard PCNL with fewer complications. Stone burden is the key factor responsible for overall stone-free rate. However, the recommendation is limited by quality of study and the sample sizes.Entities:
Keywords: mini-PCNL; nephrolithiasis; percutaneous nephrolithotomy
Year: 2020 PMID: 32055686 PMCID: PMC7015816 DOI: 10.1055/s-0040-1701225
Source DB: PubMed Journal: Surg J (N Y) ISSN: 2378-5128
Fig. 1Flowchart for study design-—duplicates in each step were excluded and final original articles were included for review.
Comparison of mini-PCNL versus standard PCNL
| Studies, Year | Number | Stone size | Sheath size (F) | Operative time (minute) | Drop in Hb (g/dL) | Hospital stay (days) | Tubeless procedure | Intraoperative complications (%) | SFR (%) | Analgesic use | Level of evidence |
Quality of study
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Giusti et al
| 40 vs. 67 | 28 vs. 31 | 13 vs. 30 | 155.5 ± 32.9 | 4.49 ± 3.10 6.31 ± 4.29 | 3.05 ± 1.69 vs. 5.07 ± 2.15 |
| NA | 77.4 vs. 94 | 5.53 ± 1.14 vs. | 3b | 6 |
|
| ||||||||||||
|
Li et al
| 93 vs. 72 | 28.6 vs. | 14–18 vs. 26 | 87.6 vs. 64.5 | 8.8 vs. 16.3 | 6.3 vs. 6.3 |
| NS | 83.9 vs. 87.5 | NA | 3b | 6 |
|
| 0.223 | 0.006 | 0.002 | 0.94 |
| NS | 0.25 | NA | ||||
|
Knoll et al
| 25 vs. 25 | 18 ± 8 vs. 23 ± 9 | 18 vs. 26 | 48 ± 17 vs. 57 ± 22 | NA |
3.8 ± 28
|
| 12 vs. 20 | 96% vs. 92% | 3 ± 3 vs. 4 ± 3 | 3b | 6 |
|
| 0.042 | NS | NA | 0.021 | NS | NS | 0.04 | |||||
|
Cheng et al,
| 72 vs. 115 | All types | 16 vs. 24 | 90–135 | 0.53 ± 0.79 | 7.3 vs. 7.5 |
| No significant difference | 70–90 | 88.7 ± 40.6 Vs. 94.3 ± 37.2 | 3b | 7 |
|
| >0.05 | <0.05 | <0.05 | >0.05 | NA | >0.05 | NS | >0.05 | ||||
|
Zhong et al
| 29 second 25 | 117 vs. 108 mm 3 | 16 vs. 25 | 116 vs. 103 | 3.2 vs. 3.5 | 9.8 vs. 7.1 | NA | 37.9 vs. 52 | 89 vs. 68 | NA | 2b | 7 |
|
| NS | 0.052 | 0.09 | 0,07 | NA | 0.3 | 0.03 | |||||
|
Mishra et al,
| 27 vs. 28 | 14.7 ± 0.3 vs. 14.9 ± 0.6 | 18.2 ± 2 vs. 26.8 ± 2 | 45.2 ± 12.6 vs. 31 ± 16.6 | 0.8 ± 0.9 vs. 1.3 ± 0.4 | 3.2 ± 0.8 vs. 4.8 ± 0.6 | 21 vs. 4 | 3 vs. 10 | 96 vs. 100 | 55.4 ± 50 vs. 70.2 ± 52 | 3b | 7 |
|
| 0.8 | 0.0008 | 0.01 | 0.001 | 0.001 | NS | NS | NS | ||||
|
| 29 vs. 27 | 10–35 | 16.5 vs. 30 | NA | 0.02 | NA | NA | NA | NA | NA | 3b | 6 |
|
| NS | 0.02 | NS | NA | NS | NS | NA | |||||
|
Elsheemy et al.
| 378 vs. 151 | 37.7 ± 2.21 vs. 37.7 ± 2.43 | 18 vs. 30 | 68.6 ± 29.09 vs. 60.49 ± 11.38 | Blood transfusion 3.7% vs. 7.9% | 2.43 ± 1.46 vs. 4.29 ± 1.28 | 248 vs. 7 | 30 vs. 31 (7.9% vs. 20.5%) | First session 86.8% vs. 90.7% | NA | 3b | 6 |
|
| 0.3 | 0.4 | 0.04 | <0.001 | <0.0001 | <0.001 | 0.2 | |||||
|
Kukreja et al,
| 61 vs. 62 | 20.6 ± 3.47 vs. | 16.5/17.5 vs. 22/24 | 25.46 ± 11.9 vs. 24.68 ± 12.45 | 0.87 ± 0.72 |
| 58 vs. 48 | NA | 93 vs. 91.9 | 0.3 ± 0.54 vs. 0.43 ± 0.65 | 3b | 7 |
|
| 0.1 | 0.3 | <0.001 | NA | 0.01 | NS | NS | |||||
|
Güler A et al
| 46 vs. 61 | >2 0 | ∓ | ∓ | ∓ | ∓ | ∓ | 76.5% vs. 71.7%, | NA | 2b | 7 | |
|
| 0.012 | NA | 0.01 | NA | 0.31 | NS | NA |
Abbreviations: SFR, stone-free rate; NS, not significant; NA, not available.
Newcastle–Ottawa Scale (score 0– 9).